Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China - Hui Li; Peng Liu; Yao Liu; Liang Huang; Yuhua Li; QingQing Cai; Huilai Zhang; Jian-Qing Mi; Zhi Wang; Ting Niu; Dehui Zou; Wenyan Yu; et al. (Journal for ImmunoTherapy of Cancer, 2024)